R&D PlatformZTI’s Nano-Platform Technology
Early-stage Cancer Diagnosis and Therapy
Based on Nanotechnology
- Head Office
- Gwanggyo R&D Center
- USA Office
(34141) BVC #121, 125 Gwahak-ro, Yuseong-
gu, Daejeon, Repulic of Korea
- TEL + 82-70-8723-0566
- FAX + 82-70-7966-0567
info@ztibio.com
(16229) 2F GyeongGi-do Business & Science Accelerator, 107 GwangGyo-ro, YeongTong-gu, SuWon-ci, GyeongGi-do, Republic of Korea
- TEL + 82-31-213-0566
- FAX + 82-31-213-0567
info@ztibio.com
Standard Radiopharmaceuticals for Theragnostic Oncology
To minimize various side effects that occur in existing cancer diagnosis and treatment, we have developed Mag-I®, ZhyperPrime®, and IronBee®. Our treatments are based on radio sensitive magnetic drug carriers and will be further developed into REMT(Radiation & Electromagnetic Therapy) to effectively kill cancer cells. See how our nanotechnology can change the future of cancer therapeutics.
CLICK
R&D PlatformZTI’s Nano-Platform Technology
Early-stage Cancer Diagnosis and Therapy
Based on Nanotechnology
To minimize various side effects that occur in existing cancer diagnosis and treatment, we have developed Mag-I®, ZhyperPrime®, and IronBee®. Our treatments are based on radio sensitive magnetic drug carriers and will be further developed into REMT(Radiation & Electromagnetic Therapy) to effectively kill cancer cells. See how our nanotechnology can change the future of cancer therapeutics.
CLICK
Product 01
Mag-I® is a Radio Pharmaceutical product that contains radioactive isotopes (iodine,
lutetium, copper, etc.) that can directly kill cancer cells. Its significance is that it can help minimize the side effects of radioactive isotopes in the body.
02
ZhyperPrime®
03
IronBee®
Product 01Mag-I®
Mag-I® is a Radio Pharmaceutical product that contains radioactive isotopes (iodine, lutetium, copper, etc.) that can directly kill cancer cells. Its significance is that it can help minimize the side effects of radioactive isotopes in the body.
02
ZhyperPrime®
03
IronBee®
Product 02
ZhyperPrime® is a synergistic product with conventional radiation cancer therapy. It
absorbs a portion of the radiation dose to generate heat or ROS (Reactive
Oxygen Species) to kill cancer cells.
01
Mag-I®
03
IronBee®
Product 02ZhyperPrime®
ZhyperPrime® is a synergistic product with conventional radiation cancer therapy. It absorbs a portion of the radiation dose to generate heat or ROS (Reactive Oxygen Species) to kill cancer cells.
01
Mag-I®
03
IronBee®
Product 03
IronBee® is an electroceutical (Electrical Pharmaceutical) nanocarrier that has excellent biocompatibility and responds to low-frequency electromagnetic fields. It is administered intravenously(IV) or precisely to the cancer and can directly kill various types of cancer cells by increased temperature or reactive oxygen species (ROS).
01
Mag-I®
02
ZhyperPrime®
Product 03IronBee®
IronBee® is an electroceutical (Electrical Pharmaceutical) nanocarrier that has excellent
biocompatibility and responds to low-frequency electromagnetic fields. It is administered by
intravenous (IV) or direct injection and can directly kill various types of cancer cells by
temperature or reactive oxygen species (ROS).
01
Mag-I®
02
ZhyperPrime®